Home
Applications
Indications
Business
EpiSwitch™
Products
EpiSwitch™ Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
Epigenetic signatures and early detection of neurodegenerative diseases: Development of stratifying biomarker for ALS in Asian cohorts.
September 25, 2017
|
In
Episwitch Publication
,
Publications
|
By
Aroul Ramadass
World Congress of Neurology; 2017 Sep 16 – 21; Kyoto, Japan
Prev
Next
Privacy Preference Center
Privacy Preferences
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.
Ok
Read more
